Us Bancorp \De\ Avanos Medical, Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 11,946 shares of AVNS stock, worth $191,374. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,946

Previous 11,848 0.83%

Holding current value

$191,374

Previous $236,000 21.61%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$19.21 - $24.69 $1,882 - $2,419	98 Added 0.83%	11,946 $287,000
Q2 2024 Aug 06, 2024	BUY	$17.85 - $20.42 $2,070 - $2,368	116 Added 0.99%	11,848 $236,000
Q1 2024 May 07, 2024	SELL	$17.97 - $22.68 $48,519 - $61,236	-2,700 Reduced 18.71%	11,732 $233,000
Q4 2023 Feb 09, 2024	BUY	$17.64 - $22.99 $29,758 - $38,784	1,687 Added 13.24%	14,432 $323,000
Q3 2023 Nov 03, 2023	BUY	$19.93 - $26.31 $11,280 - $14,891	566 Added 4.65%	12,745 $257,000
Q2 2023 Aug 09, 2023	BUY	$22.53 - $30.98 $21,921 - $30,143	973 Added 8.68%	12,179 $311,000
Q1 2023 May 09, 2023	BUY	$26.92 - $31.75 $21,105 - $24,892	784 Added 7.52%	11,206 $333,000
Q4 2022 Feb 13, 2023	SELL	$19.88 - $27.37 $16,480 - $22,689	-829 Reduced 7.37%	10,422 $282,000
Q3 2022 Oct 27, 2022	SELL	$21.56 - $29.59 $10,715 - $14,706	-497 Reduced 4.23%	11,251 $245,000
Q2 2022 Aug 01, 2022	BUY	$24.87 - $34.68 $6,963 - $9,710	280 Added 2.44%	11,748 $322,000
Q1 2022 May 11, 2022	BUY	$28.87 - $35.77 $36,347 - $45,034	1,259 Added 12.33%	11,468 $383,000
Q4 2021 Feb 11, 2022	BUY	$29.25 - $36.02 $79,735 - $98,190	2,726 Added 36.43%	10,209 $354,000
Q3 2021 Nov 10, 2021	BUY	$31.2 - $38.5 $93,756 - $115,692	3,005 Added 67.11%	7,483 $233,000
Q2 2021 Aug 05, 2021	SELL	$36.37 - $45.72 $72 - $91	-2 Reduced 0.04%	4,478 $163,000
Q1 2021 Apr 28, 2021	BUY	$43.5 - $53.4 $4,828 - $5,927	111 Added 2.54%	4,480 $196,000
Q4 2020 Feb 04, 2021	SELL	$33.15 - $49.5 $33,017 - $49,302	-996 Reduced 18.56%	4,369 $200,000
Q3 2020 Nov 10, 2020	BUY	$28.67 - $34.32 $9,719 - $11,634	339 Added 6.74%	5,365 $178,000
Q2 2020 Aug 07, 2020	SELL	$23.48 - $33.86 $4,038 - $5,823	-172 Reduced 3.31%	5,026 $148,000
Q1 2020 May 13, 2020	SELL	$20.64 - $34.41 $15,149 - $25,256	-734 Reduced 12.37%	5,198 $140,000
Q4 2019 Feb 04, 2020	BUY	$31.89 - $47.34 $1,722 - $2,556	54 Added 0.92%	5,932 $199,000
Q3 2019 Nov 08, 2019	SELL	$32.06 - $44.0 $33,406 - $45,848	-1,042 Reduced 15.06%	5,878 $220,000
Q2 2019 Aug 13, 2019	SELL	$37.68 - $46.52 $5,388 - $6,652	-143 Reduced 2.02%	6,920 $301,000
Q1 2019 May 08, 2019	BUY	$39.84 - $51.04 $57,449 - $73,599	1,442 Added 25.65%	7,063 $302,000
Q4 2018 Feb 13, 2019	SELL	$41.16 - $66.67 $28,935 - $46,869	-703 Reduced 11.12%	5,621 $251,000
Q3 2018 Nov 01, 2018	BUY	$55.13 - $72.65 $348,642 - $459,438	6,324 New	6,324 $433,000

Others Institutions Holding AVNS

# of Institutions

274

Shares Held

42.2M

Call Options Held

5.4K

Put Options Held

View Full List

About AVANOS MEDICAL, INC.

Ticker AVNS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 46,487,000
Market Cap $745M
Description
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...

More about AVNS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account